MedTrace Logo

Molecular & Clinical Evaluation of Low HDL Syndromes

NCT00006295 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 370

Last updated 2020-01-14

No results posted yet for this study

Summary

To study the genetic cause of low HDL-C, a risk factor for premature atherosclerotic vascular disease in patients with normal total cholesterol. The focus is primarily on the identification of a single mutation, as has been demonstrated in one family.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Maryland, Baltimore

    lead OTHER

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-08-31
Primary Completion
2006-07-31
Completion
2006-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00006295 on ClinicalTrials.gov